Your browser is no longer supported. Please, upgrade your browser.
IMRA [NASD]
IMARA Inc.
Index- P/E- EPS (ttm)-2.53 Insider Own14.85% Shs Outstand24.90M Perf Week-5.37%
Market Cap50.21M Forward P/E- EPS next Y-2.74 Insider Trans25.71% Shs Float22.37M Perf Month-15.65%
Income-48.60M PEG- EPS next Q-0.75 Inst Own65.10% Short Float0.35% Perf Quarter-46.99%
Sales- P/S- EPS this Y-149.70% Inst Trans-2.10% Short Ratio0.49 Perf Half Y-66.55%
Book/sh3.99 P/B0.49 EPS next Y1.20% ROA-55.20% Target Price18.50 Perf Year-85.88%
Cash/sh3.97 P/C0.49 EPS next 5Y- ROE-59.90% 52W Range1.91 - 14.98 Perf YTD-13.78%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-87.05% Beta-
Dividend %- Quick Ratio14.70 Sales past 5Y- Gross Margin- 52W Low1.57% ATR0.17
Employees27 Current Ratio14.70 Sales Q/Q- Oper. Margin- RSI (14)31.55 Volatility5.52% 7.37%
OptionableYes Debt/Eq0.00 EPS Q/Q23.50% Profit Margin- Rel Volume0.80 Prev Close1.91
ShortableYes LT Debt/Eq0.00 EarningsNov 09 BMO Payout- Avg Volume161.10K Price1.94
Recom1.70 SMA20-13.47% SMA50-31.92% SMA200-63.04% Volume128,906 Change1.57%
Aug-11-21Downgrade Morgan Stanley Overweight → Equal-Weight $33 → $12
May-12-21Resumed Citigroup Buy $30
Aug-17-20Upgrade Citigroup Neutral → Buy $34 → $30
Jun-30-20Downgrade Citigroup Buy → Neutral $30 → $34
Apr-06-20Initiated SVB Leerink Outperform $25
Apr-06-20Initiated Morgan Stanley Overweight $35
Apr-06-20Initiated Cowen Outperform $25
Jan-05-22 07:00AM  
Dec-14-21 07:00AM  
Dec-13-21 07:00AM  
Nov-22-21 10:36AM  
07:00AM  
Nov-16-21 02:30PM  
11:34AM  
07:00AM  
Nov-09-21 07:00AM  
Nov-08-21 07:00AM  
Nov-04-21 04:01PM  
09:17AM  
Sep-15-21 07:00AM  
Sep-06-21 08:08AM  
Sep-03-21 07:00AM  
Aug-06-21 07:00AM  
Aug-05-21 07:15AM  
Aug-02-21 06:07PM  
Jul-30-21 07:00AM  
Jul-14-21 06:59AM  
Jul-13-21 10:58PM  
04:01PM  
Jun-30-21 07:00AM  
Jun-23-21 02:58PM  
Jun-17-21 07:00AM  
Jun-11-21 03:00AM  
Jun-08-21 04:41AM  
Jun-04-21 07:00AM  
May-11-21 07:00AM  
06:30AM  
May-04-21 07:00AM  
Mar-29-21 07:00AM  
Mar-22-21 04:05PM  
Mar-17-21 07:00AM  
Mar-15-21 11:00AM  
Mar-14-21 08:16PM  
Mar-12-21 05:45AM  
Mar-10-21 02:40AM  
02:40AM  
Mar-05-21 07:00AM  
06:30AM  
Feb-26-21 09:30PM  
Feb-19-21 07:00AM  
Jan-20-21 07:00AM  
Jan-06-21 05:21PM  
07:00AM  
Dec-10-20 01:01AM  
Dec-07-20 07:00AM  
Nov-30-20 10:36PM  
07:00AM  
Nov-17-20 07:00AM  
Nov-05-20 07:00AM  
Oct-31-20 08:00AM  
Oct-29-20 07:00AM  
Oct-16-20 07:00AM  
Sep-02-20 07:00AM  
Aug-25-20 07:00AM  
Aug-14-20 08:26AM  
07:00AM  
Aug-13-20 04:01PM  
Aug-07-20 07:00AM  
Jul-30-20 07:00AM  
Jun-29-20 04:01PM  
Jun-25-20 07:00AM  
Jun-24-20 07:00AM  
Jun-22-20 01:57PM  
Jun-13-20 08:44AM  
Jun-12-20 07:46AM  
07:00AM  
May-21-20 07:00AM  
May-07-20 07:00AM  
May-06-20 07:00AM  
May-04-20 07:00AM  
Apr-23-20 07:00AM  
Mar-11-20 09:57PM  
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. It develops IMR-687, an oral, once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and -thalassemia. The company was incorporated in 2016 and is headquartered in Boston, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
New Enterprise Associates 14, 10% OwnerJan 14Sale1.919,70718,5833,466,714Jan 14 05:04 PM
New Enterprise Associates 14, 10% OwnerJan 13Sale1.937,20913,8863,476,421Jan 14 05:04 PM
New Enterprise Associates 14, 10% OwnerJan 12Sale2.024,6349,3573,483,630Jan 14 05:04 PM
New Enterprise Associates 14, 10% OwnerJan 11Sale2.042,4094,9193,488,264Jan 11 05:54 PM
New Enterprise Associates 14, 10% OwnerJan 10Sale2.001,7513,5023,490,673Jan 11 05:54 PM
New Enterprise Associates 14, 10% OwnerJan 07Sale2.0814,60030,3183,492,424Jan 11 05:54 PM
New Enterprise Associates 14, 10% OwnerJan 06Sale2.1610,25722,2053,507,024Jan 06 05:35 PM
New Enterprise Associates 14, 10% OwnerJan 05Sale2.258,20018,4393,517,281Jan 06 05:35 PM
New Enterprise Associates 14, 10% OwnerJan 04Sale2.3413,45931,5443,525,481Jan 06 05:35 PM
New Enterprise Associates 14, 10% OwnerJan 03Sale2.3444,665104,3963,538,940Jan 03 08:15 PM
New Enterprise Associates 14, 10% OwnerDec 31Sale2.2549,953112,4093,583,605Jan 03 08:15 PM
New Enterprise Associates 14, 10% OwnerDec 30Sale2.2921,85850,0663,633,558Jan 03 08:15 PM
New Enterprise Associates 14, 10% OwnerDec 29Sale2.3015,19634,9543,655,416Dec 29 06:35 PM
New Enterprise Associates 14, 10% OwnerDec 28Sale2.3424,58057,5393,670,612Dec 29 06:35 PM
New Enterprise Associates 14, 10% OwnerDec 27Sale2.4227,65167,0073,695,192Dec 29 06:35 PM
New Enterprise Associates 14, 10% OwnerDec 23Sale2.4123,96157,7463,722,843Dec 27 04:34 PM
New Enterprise Associates 14, 10% OwnerDec 22Sale2.3220,10946,6793,746,804Dec 27 04:34 PM
New Enterprise Associates 14, 10% OwnerDec 21Sale2.3241,22295,8043,766,913Dec 27 04:34 PM
New Enterprise Associates 14, 10% OwnerDec 20Sale2.2685,123192,6043,808,135Dec 27 04:34 PM
New Enterprise Associates 14, 10% OwnerDec 16Sale2.2344,993100,5463,893,258Dec 27 04:34 PM
New Enterprise Associates 14, 10% OwnerDec 15Sale2.2828,81765,6853,938,251Dec 27 04:34 PM
New Enterprise Associates 14, 10% OwnerDec 14Sale2.5615,09338,6433,967,068Dec 27 04:34 PM
New Enterprise Associates 14, 10% OwnerDec 13Sale2.8317,50149,5583,982,161Dec 27 04:34 PM
New Enterprise Associates 14, 10% OwnerDec 10Sale2.838,66724,5413,999,662Dec 27 04:34 PM
New Enterprise Associates 14, 10% OwnerDec 09Sale2.955,66616,6934,008,329Dec 27 04:34 PM
ORBIMED ADVISORS LLCDirectorJul 16Buy6.001,666,6669,999,9961,666,666Jul 16 04:27 PM
Bonita David PDirectorJul 16Buy6.001,666,6669,999,9961,666,666Jul 16 04:21 PM
Chin MarkDirectorJul 16Buy6.001,333,3337,999,9982,344,072Jul 28 08:50 AM